CN102791878A - 黑色素瘤特异性生物标志物 - Google Patents

黑色素瘤特异性生物标志物 Download PDF

Info

Publication number
CN102791878A
CN102791878A CN2010800550196A CN201080055019A CN102791878A CN 102791878 A CN102791878 A CN 102791878A CN 2010800550196 A CN2010800550196 A CN 2010800550196A CN 201080055019 A CN201080055019 A CN 201080055019A CN 102791878 A CN102791878 A CN 102791878A
Authority
CN
China
Prior art keywords
melanoma
patient
biomarker
fragment
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010800550196A
Other languages
English (en)
Chinese (zh)
Inventor
R·摩根
H·S·潘德哈
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Surrey
Original Assignee
University of Surrey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Surrey filed Critical University of Surrey
Publication of CN102791878A publication Critical patent/CN102791878A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
CN2010800550196A 2009-12-04 2010-07-13 黑色素瘤特异性生物标志物 Pending CN102791878A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0921329.9 2009-12-04
GBGB0921329.9A GB0921329D0 (en) 2009-12-04 2009-12-04 Biomarker
PCT/GB2010/001334 WO2011067549A1 (en) 2009-12-04 2010-07-13 Melanoma specific biomarker

Publications (1)

Publication Number Publication Date
CN102791878A true CN102791878A (zh) 2012-11-21

Family

ID=41641989

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010800550196A Pending CN102791878A (zh) 2009-12-04 2010-07-13 黑色素瘤特异性生物标志物

Country Status (14)

Country Link
US (1) US20120263654A1 (enExample)
EP (1) EP2507384A1 (enExample)
JP (1) JP2013512668A (enExample)
CN (1) CN102791878A (enExample)
AU (1) AU2010326433A1 (enExample)
BR (1) BR112012013041A2 (enExample)
CA (1) CA2782034A1 (enExample)
GB (1) GB0921329D0 (enExample)
IL (1) IL219834A0 (enExample)
IN (1) IN2012DN04381A (enExample)
MX (1) MX2012006229A (enExample)
RU (1) RU2012121096A (enExample)
WO (1) WO2011067549A1 (enExample)
ZA (1) ZA201203517B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116003567A (zh) * 2017-02-23 2023-04-25 成均生物株式会社 En2蛋白的免疫原性片段肽或特异性识别其的抗体组合物

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2294216A4 (en) 2008-05-14 2011-11-23 Dermtech Int DIAGNOSIS OF MELANOMA AND SOLAR LENTIGO BY ANALYSIS OF NUCLEIC ACIDS
US20150005184A1 (en) * 2013-06-28 2015-01-01 Dermtech International Diagnosis of melanoma by nucleic acid analysis
WO2019161126A1 (en) 2018-02-14 2019-08-22 Dermtech, Inc. Novel gene classifiers and uses thereof in non-melanoma skin cancers
US11035849B2 (en) 2015-04-13 2021-06-15 The Translational Genomics Research Institute Predicting the occurrence of metastatic cancer using epigenomic biomarkers and non-invasive methodologies
EP3822367A1 (en) * 2015-06-24 2021-05-19 Oxford BioDynamics PLC Detection processes using sites of chromosome interaction
JP2022524641A (ja) 2019-03-26 2022-05-09 ダームテック，インク． 皮膚癌における新規な遺伝子分類子とその使用
RU2766739C1 (ru) * 2021-04-12 2022-03-15 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр онкологии имени Н.Н. Блохина" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ онкологии им. Н.Н. Блохина" Минздрава России) Способ прогноза эффективности терапии меланомы

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008075056A1 (en) * 2006-12-19 2008-06-26 The University Of Surrey Cancer biomarkers
US20080182257A1 (en) * 2006-11-15 2008-07-31 The Regents Of The University Of California Detection of chromosomal region copy number changes to diagnose melanoma
WO2009131733A1 (en) * 2008-04-21 2009-10-29 The Trustees Of Columbia University In The City Of New York Gab2 amplification in melanoma

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2469089A1 (en) * 2003-07-08 2005-01-08 Institut De Recherches Cliniques De Montreal En-2 gene, disgnostic and therapeutic uses thereof
US20070154889A1 (en) * 2004-06-25 2007-07-05 Veridex, Llc Methods and reagents for the detection of melanoma
US7615349B2 (en) * 2006-09-07 2009-11-10 H. Lee Moffitt Cancer Center And Research Institute, Inc. Melanoma gene signature

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080182257A1 (en) * 2006-11-15 2008-07-31 The Regents Of The University Of California Detection of chromosomal region copy number changes to diagnose melanoma
WO2008075056A1 (en) * 2006-12-19 2008-06-26 The University Of Surrey Cancer biomarkers
WO2009131733A1 (en) * 2008-04-21 2009-10-29 The Trustees Of Columbia University In The City Of New York Gab2 amplification in melanoma

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BENAYED,R. ET AL: "NM_001427", 《GENBANK》 *
BENAYED,R., ET AL: "NP_001418", 《GENBANK》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116003567A (zh) * 2017-02-23 2023-04-25 成均生物株式会社 En2蛋白的免疫原性片段肽或特异性识别其的抗体组合物

Also Published As

Publication number Publication date
WO2011067549A1 (en) 2011-06-09
MX2012006229A (es) 2012-06-19
IL219834A0 (en) 2012-07-31
RU2012121096A (ru) 2014-01-10
BR112012013041A2 (pt) 2016-10-11
ZA201203517B (en) 2013-02-27
IN2012DN04381A (enExample) 2015-08-07
US20120263654A1 (en) 2012-10-18
JP2013512668A (ja) 2013-04-18
CA2782034A1 (en) 2011-06-09
EP2507384A1 (en) 2012-10-10
GB0921329D0 (en) 2010-01-20
AU2010326433A1 (en) 2012-06-07

Similar Documents

Publication Publication Date Title
CN102791878A (zh) 黑色素瘤特异性生物标志物
JP5947040B2 (ja) バイオマーカー
US20120183554A1 (en) Biomarker
CN102575290A (zh) 用于妇科癌症的生物标志物er2
US9803196B2 (en) Compositions and methods for treating, diagnosing and monitoring disease
WO2016102560A1 (en) Glycosylated biomarker

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20121121